Valentis, Inc. has subscribed to R&D Manage.
March 2001 — Valentis, Inc, is taking the discoveries of genomics research and applying proprietary delivery systems to create therapeutics with improved safety, efficacy or dosing convenience. Valentis has what is believed to be the broadest array of technologies and intellectual property for the delivery of biopharmaceuticals in the industry. R&D Manage will be integrated with Platinum and the local time reporting system. The company has centers in three locations: The Woodlands, Texas, which houses the team focused on preclinical Research & Development; London, England, where PolyMASC operates as a wholly-owned subsidiary and focuses on polymer-based delivery; and Burlingame, California, which is the company headquarters as well as the center for manufacturing and clinical development. R&D Manage will be rolled out to the US locations in April 2001.
Sunesis and Cytokinetics Inc. have also joined our R&D Manage subscription community.
February 2001 — Sunesis Pharmaceuticals is applying a revolutionary new approach to drug discovery that is based on a novel chemical methodology combined with critical insights into the nature of molecular recognition between natural macromolecules and their substrates or ligands. Sunesis will be using R&D Manage™ and the electronic integration with Quick Books. Cytokinetics Inc. is focused on the complementary missions of drug discovery and the commercialization of novel cellular bioinformatics technologies. We are excited to integrate R&D Manage™ with the General Ledger of Microsoft Dynamics accounting system.
Intrabiotics has subscribed to R&D Manage.
February 2001 — Intrabiotics Pharmaceuticals Inc, is a biopharmaceutical company developing novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases, including those related to the phenomenon of multi-drug resistant microbes and the infectious complications of neutropenia. R&D Manage™ will be integrated with MAS90 and local time reporting system.
BioSpace.com has subscribed to R&D Manage.
November 2000 — BioSpace.com, Inc. is the most heavily trafficked business-to-business life sciences site on the Internet today. The company has selected R&D Manage as the tool to budget and forecast their P&L by project and by organization.
GeneSoft chooses R&D Manage over Hyperion.
September 2000 — GeneSoft, Inc. a South San Francisco company focused on pharmaceuticals that modulate gene expression, has subscribed to R&D Manage with Quick Books to budget and forecast R&D expenses.
Collabra Pharma leases R&D Manage.
August 2000 — Collabra Pharma, Inc., a drug development company based in South San Francisco, has chosen R&D Manage™ with Quick Books to manage their budgeting and tracking of R&D expenses.